AYR Wellness Faces Filing Delays Amid Debt Negotiations

The latest announcement is out from Ayr Wellness ( ($TSE:AYR.A) ).

AYR Wellness Inc. has announced a delay in filing its interim financial statements for the first quarter of 2025 due to ongoing negotiations with creditors and the assessment of debt obligations. This delay has led to a failure-to-file cease-trade order from the Ontario Securities Commission, suspending trading of AYR’s securities in Canadian jurisdictions. Despite this, AYR does not anticipate any impact on its regular operations and is working to complete the filings promptly, with an update expected by June 27, 2025.

The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.

Spark’s Take on TSE:AYR.A Stock

According to Spark, TipRanks’ AI Analyst, TSE:AYR.A is a Neutral.

Ayr Wellness faces significant financial and operational challenges, as evidenced by its negative financial performance, poor valuation metrics, and bearish market momentum. The recent regulatory issues further exacerbate the situation, overshadowing any strategic efforts discussed in the earnings call.

To see Spark’s full report on TSE:AYR.A stock, click here.

More about Ayr Wellness

AYR Wellness Inc. is a vertically integrated U.S. multi-state cannabis business, operating as both a retailer with over 90 licensed dispensaries and a house of cannabis consumer packaged goods brands. The company is dedicated to providing high-quality cannabis products to its customers and patients while maintaining a commitment to its team members and the communities it serves.

Average Trading Volume: 116,753

Technical Sentiment Signal: Sell

Current Market Cap: C$18.1M

See more insights into AYR.A stock on TipRanks’ Stock Analysis page.